These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 24508578)

  • 1. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth.
    Anagnostou E; Soorya L; Brian J; Dupuis A; Mankad D; Smile S; Jacob S
    Brain Res; 2014 Sep; 1580():188-98. PubMed ID: 24508578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.
    Tachibana M; Kagitani-Shimono K; Mohri I; Yamamoto T; Sanefuji W; Nakamura A; Oishi M; Kimura T; Onaka T; Ozono K; Taniike M
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):123-7. PubMed ID: 23480321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial.
    Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL
    J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
    Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
    JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.
    Okamoto Y; Ishitobi M; Wada Y; Kosaka H
    CNS Neurol Disord Drug Targets; 2016; 15(5):564-77. PubMed ID: 27071789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.
    Anagnostou E; Soorya L; Chaplin W; Bartz J; Halpern D; Wasserman S; Wang AT; Pepa L; Tanel N; Kushki A; Hollander E
    Mol Autism; 2012 Dec; 3(1):16. PubMed ID: 23216716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.
    Quintana DS; Alvares GA; Hickie IB; Guastella AJ
    Neurosci Biobehav Rev; 2015 Feb; 49():182-92. PubMed ID: 25526824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.
    Domes G; Heinrichs M; Kumbier E; Grossmann A; Hauenstein K; Herpertz SC
    Biol Psychiatry; 2013 Aug; 74(3):164-71. PubMed ID: 23510581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.
    Aoki Y; Yahata N; Watanabe T; Takano Y; Kawakubo Y; Kuwabara H; Iwashiro N; Natsubori T; Inoue H; Suga M; Takao H; Sasaki H; Gonoi W; Kunimatsu A; Kasai K; Yamasue H
    Brain; 2014 Nov; 137(Pt 11):3073-86. PubMed ID: 25149412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of multiple-dose intranasal oxytocin administration on social responsiveness in children with autism: a randomized, placebo-controlled trial.
    Daniels N; Moerkerke M; Steyaert J; Bamps A; Debbaut E; Prinsen J; Tang T; Van der Donck S; Boets B; Alaerts K
    Mol Autism; 2023 Apr; 14(1):16. PubMed ID: 37081454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin and the social brain: neural mechanisms and perspectives in human research.
    Kanat M; Heinrichs M; Domes G
    Brain Res; 2014 Sep; 1580():160-71. PubMed ID: 24216134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder.
    Cai Q; Feng L; Yap KZ
    Psychiatry Clin Neurosci; 2018 Mar; 72(3):140-151. PubMed ID: 29232031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin and autism: a systematic review of randomized controlled trials.
    Preti A; Melis M; Siddi S; Vellante M; Doneddu G; Fadda R
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):54-68. PubMed ID: 24679173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.
    Sikich L; Kolevzon A; King BH; McDougle CJ; Sanders KB; Kim SJ; Spanos M; Chandrasekhar T; Trelles MDP; Rockhill CM; Palumbo ML; Witters Cundiff A; Montgomery A; Siper P; Minjarez M; Nowinski LA; Marler S; Shuffrey LC; Alderman C; Weissman J; Zappone B; Mullett JE; Crosson H; Hong N; Siecinski SK; Giamberardino SN; Luo S; She L; Bhapkar M; Dean R; Scheer A; Johnson JL; Gregory SG; Veenstra-VanderWeele J
    N Engl J Med; 2021 Oct; 385(16):1462-1473. PubMed ID: 34644471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial.
    Quintana DS; Westlye LT; Hope S; Nærland T; Elvsåshagen T; Dørum E; Rustan Ø; Valstad M; Rezvaya L; Lishaugen H; Stensønes E; Yaqub S; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2017 May; 7(5):e1136. PubMed ID: 28534875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders.
    Yamasue H
    Psychiatry Clin Neurosci; 2016 Feb; 70(2):89-99. PubMed ID: 26394796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal oxytocin effects on social cognition: a critique.
    Evans SL; Dal Monte O; Noble P; Averbeck BB
    Brain Res; 2014 Sep; 1580():69-77. PubMed ID: 24239931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term exposure to intranasal oxytocin in a mouse autism model.
    Bales KL; Solomon M; Jacob S; Crawley JN; Silverman JL; Larke RH; Sahagun E; Puhger KR; Pride MC; Mendoza SP
    Transl Psychiatry; 2014 Nov; 4(11):e480. PubMed ID: 25386957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacological interventions in autism spectrum disorder.
    Politte LC; Henry CA; McDougle CJ
    Harv Rev Psychiatry; 2014; 22(2):76-92. PubMed ID: 24614763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders.
    Lukas M; Neumann ID
    Behav Brain Res; 2013 Aug; 251():85-94. PubMed ID: 22981649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.